PEGylated L-asparaginase from E. coli (Oncospar) was approved by the FDA for the treatment of patients with acute lymphoblast leukemia (Table S2, Supplementary Materials) [91,92,93,94,95,96,97,98]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.